Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120
-
Add time:08/26/2019 Source:sciencedirect.com
The synthesis of novel building blocks corresponding to the Tn [α-D-GalNAc-(1 → O)-Thr] an sialyl Tn [α-D-Neu5Ac-(2→6)-α-D-GalNAc-(1→O)-Thr] epitopes is descibed. The Tn building block was prepared from 4-methylphenyl 2-azido-2-deoxy-1-thio-β-D-galactopyranoside in four steps (42% yield) and carries tert-butyldimethylsilyl protective groups for the GalNAc moiety. Further conversion into a sialyl Tn building block, having acetyl protective groups for the sialic acid unit, was achieved in an additional four steps (37% yield). Both building blocks were used, in low excess (<20%), for Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp 120. The silyl protective groups of the Tn epitope was completely removed simultaneously with acid catalyzed cleavage of the glycopeptides from the solid phase. Hydrolysis of the sialic acid residue was not encountered during acid catalyzed cleavage of the sialyl Tn glycopeptide from the solid phase or during purification, even though glycosides of sialic acid are labile under acidic conditions.
We also recommend Trading Suppliers and Manufacturers of HIV (GP120) FRAGMENT (254-274) (cas 113944-46-0). Pls Click Website Link as below: cas 113944-46-0 suppliers
Prev:ReviewCurrent antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses
Next:ReviewHuman immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Characterization by serial deletion competition ELISAs of HIV-1 V3 loop epitopes recognized by monoclonal antibodies08/29/2019
- High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination08/28/2019
- ReviewHuman immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review☆08/27/2019
- ReviewCurrent antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses08/25/2019


